The Latest Breaking News on Diabetes

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.

Tandem Diabetes Care Inc.’s (NASDAQ:TNDM) stock plunged on Thursday after the company cut its annual guidance.

The study found eating three servings of fries a week could increase your risk of developing type 2 diabetes by 20 percent

Baking, boiling or mashing potatoes raises risk by 5% and replacing with whole grains lowers risk significantly

Danish company to cut costs and consider layoffs after competition from Mounjaro and the copycat market

Tech entrepreneur Bryan Johnson, who spends $2 million annually on anti-aging treatments, refutes claims that Novo Nordisk AS‘s (NYSE:NVO) Ozempic demonstrates anti-aging properties. Johnson disputed a post on social platform X suggesting the diabetes drug reverses biological aging by 3.1 years.

The popular weight loss drug shrank the liver of mice by nearly half their size, researchers said

Doctors have warned that patients are being ‘set up for failure’ due to mismanagement of the rollout of Mounjaro